Flaxseed reduces total and LDL cholesterol concentrations in Native American postmenopausal women

Journal of Women's Health

Volumn 17, Issue 3, 2008, Pages 355-366

  Patade, Anagha ^a   Devareddy, Latha ^b   Lucas, Edralin A ^a   Korlagunta, Kiranmayi ^a   Daggy, Bruce P ^a   Arjmandi, Bahram H ^c  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ARKANSAS   (United States)

^c FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERCHOLESTEROLEMIA; LINSEED; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; VENOUS BLOOD;

CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FLAX; HUMANS; HYPERCHOLESTEROLEMIA; INDIANS, NORTH AMERICAN; MIDDLE AGED; PHYTOTHERAPY; POSTMENOPAUSE; SEEDS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 41449086781     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0359     Document Type: Article

References (49)

1. American Heart Association. Heart and stroke facts: Statistical updates-2005. Available at www.americanheart. org/downloadable/heart/ 1105390918119HDSStats2005Update.pdf Accessed May 17, 2005.
2. American Heart Association. CHD prevalence. Statistical updates-2005. Available at www.americanheart. org/downloadable/heart/ 1105390918119HDSStats2005Update.pdf Accessed May 17, 2005.
3. Hoyert DL, Kung HC, Smith BL. Deaths: Preliminary data for 2003. Natl Vital Stat Rep 2005;53:1.
4. Sewell JL, Malasky BR, Gedney CL, et al. The increasing incidence of coronary artery disease and cardiovascular risk factors among a Southwest Native American tribe: The White Mountain Apache Heart Study. Arch Intern Med 2002;162:1368.
5. Oser CS, Harwell TS, Strasheim, et al. Increasing prevalence of cardiovascular risk factors among American Indians in Montana. Am J Prev Med 2005;28:295.
6. Welty TK, Rhoades, DA, Yeh F, et al. Changes in cardiovascular disease risk factors among American Indians. The Strong Heart Study. Ann Epidemiol 2002;12:97.
7. Raza JA, Reinhart RA, Movahed A. Ischemic heart disease in women and the role of hormone therapy. Int J Cardiol 2004;96:7.
8. Sekuri C, Eser E, Akpinar, et al. Cardiovascular disease risk factors in post menopausal women in West Anatolia. Jpn Heart J 2004;45:119.
9. Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 1990;12:321.
10. Fukami K, Koike K, Hirota K, Yoshikawa H, Miyake A. Perimenopausal changes in serum lipids and lipoproteins: A 7-year longitudinal study. Maturitas 1995;22:193.
11. Sjoberg L, Kaaja, R, Tuomilehto J. Epidemiology of postmenopausal hypertension. Int J Clin Pract Suppl 2004;139:4.
12. Stang J, Zephier E M, Story M, et al. V. Dietary intakes of nutrients thought to modify cardiovascular risk from three groups of American Indians: The Strong Heart Dietary Study, Phase II. J Am Diet Assoc 2005;105:1895.
13. Thompson LU, Seidl MM, Rickard SE, Orcheson LJ, Fong HH. Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 1996;26:159.
14. Collins BM, McLachlan JA, Arnold SF. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids 1997;62:365.
15. Prasad K. Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed. Mol Cell Biochem 1997;168:117.
16. Prasad, K. Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol. 2000;9:220.
17. Kitts DD, Yuan YV, Wijewickreme AN, Thompson LU. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 1999;202:91.
18. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 1999;99:1355.
19. Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H, Salonen JT. Risk of acute coronary events according to serum concentrations of enterolactone: A prospective population-based case-control study. Lancet. 1999;354:2112.
20. Bierenbaum ML, Reichstein R, Watkins TR. Reducing atherogenic risk in hyperlipemic humans with flax seed supplementation: A preliminary report. J Am Coll Nutr 1993;12:501.
21. Cunnane SC, Hamadeh MJ, Liede AC, Thompson LU, Wolever TM, Jenkins DJ. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 1995;61:62.
22. Jenkins DJ, Kendall CW, Vidgen E, et al. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: A controlled crossover trial. Am J Clin Nutr. 1999;69:395.
23. Dodin S, Lemay A, Jacues H, Legare F, Forest JC, Masse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: A randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 2005;90:1390.
24. Lucas EA, Wild RD, Hammond LJ, et al. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 2002;87:1527.
25. Arjmandi BH, Khan DA, Juma, S, et al. Whole flaxseed consumption lowers serum LDL-cholesterol and lipoprotein(a) concentrations in postmenopausal women. Nutr Res 1998;18:1203.
26. Lucas, EA, Lightfoot SA, Hammond LJ, et al. Flaxseed reduces plasma cholesterol and atherosclerotic lesion formation in ovariectomized Golden Syrian hamsters. Atherosclerosis 2004;173:223.
27. Li J, Wang J, Kaneko T, in L, Sato A. Effects of fiber intake on the blood pressure, lipids, and heart rate in Goto Kakizaki rats. Nutrition 2004;20:1003.
28. Arjmandi BH, Sohn E, Juma S, Murthy SR, Daggy BP. Native and partially hydrolyzed psyllium have comparable effects on cholesterol metabolism in rats. J Nutr 1997;127:463.
29. Arjmandi BH, Craig J, Nathani S, Reeves RD. Soluble dietary fiber and cholesterol influence in vivo hepatic and intestinal cholesterol biosynthesis in rats. J Nutr 1992;122:1559.
30. Jenkins DJ, Kendall CW, Marchie A, et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr 2005;81:380.
31. Behall KM, Scholfield DJ, Hallfrisch J. Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. Am J Clin Nutr 2004;80:1185.
32. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499.
33. Mandasescu S, Mocanu V, Dascalita AM, et al. Flaxseed supplementation in hyperlipidemic patients. Rev Med Chir Soc Med Nat Iasi 2005;109:502.
34. Thompson LU, Cunnane SC. Structure, composition and variety development of flaxseed. In: Flaxseed in human nutrition. 2nd ed. American Oil Chemists' Society Press, Champaign, IL, 2003:1.
35. Thompson LU, Cunnane SC. Dietary source and metabolism of alpha-linolenic acid. Flaxseed in human nutrition. 2nd ed. American Oil Chemists' Society Press, Champaign, IL, 2003:63.
36. Stuglin C, Prasad K. Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and liver and kidney enzymes in healthy humans. J Cardiovasc Pharmacol Ther 2005;10:23.
37. Dewailly E, Blanchet C, Gingras S, Lemieux S, Holub BJ. Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr 2002;76:85.
38. Shinozaki K, Kambayashi J, Kawasaki T, et al. The long-term effect of eicosapentaenoic acid on serum levels of lipoprotein(a) and lipids in patients with vascular disease. J Atheroscler Thromb 1996;2:107.
39. Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: A randomized controlled trial. JAMA 2001;285:1482.
40. Chapman CM, Beilby JP, Mcuillan BM, Thompson PL, Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004;35:1619.
41. Huang ZS, Wang CH, Yip PK, Yang CY, Lee TK. In hypercholesterolemia, lower peripheral monocyte count is uniue among the major predictors of atherosclerosis. Arterioscler Thromb Vasc Biol 1996;16:256.
42. Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638.
43. Prasad K. Effect of chronic administration of lignan complex isolated from flaxseed on the hemopoietic system. Mol Cell Biochem 2005;270:139.
44. Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL. Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women. Nutr Cancer 2001;39:58.
45. Rajesha J, Murthy KN, Kumar MK, Madhusudhan B, Ravishankar GA. Antioxidant potentials of flaxseed by in vivo model. J Agric Food Chem 2006;54:3794.
46. Prasad K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 1997;132:69.
47. Ogborn MR, Nitschmann E, Weiler H, Leswick D, Bankovic-Calic N. Flaxseed ameliorates interstitial nephritis in rat polycystic kidney disease. Kidney Int 1999;55:417.
48. Prasad K. Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis 2005;179:269.
49. Prasad K. Flaxseed: A source of hypocholesterolemic and antiatherogenic agents. Drugs New Perspect. 2000;13:99.